An assessment of the NIH Women's Health Initiative

Detalles Bibliográficos
Autor principal: Institute of Medicine (U.S.).
Autor Corporativo: Institute of Medicine (U.S.). Committee to Review the NIH Women's Health Initiative (-)
Otros Autores: Thaul, Susan (-), Hotra, Dana
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press 1993.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820325306719
Tabla de Contenidos:
  • An Assessment of the NIH Women's Health Initiative
  • Copyright
  • Preface
  • Contents
  • List of Figures
  • Executive Summary
  • THE WOMEN'S HEALTH INITIATIVE
  • THE IOM STUDY
  • FINDINGS AND SUGGESTIONS
  • Clinical Trial
  • Factorial Design
  • Sample Characteristics
  • Proposed Analytic Techniques
  • Ethics
  • Minority Analysis Plan
  • Specificity of Intervention and Effect
  • Outcome Definition and Measurement
  • Recruitment, Retention, and Adherence
  • Secular Trends
  • Provision of Health Care Services to Participants
  • Cost
  • Observational Study
  • Community Prevention Study
  • RECOMMENDATIONS
  • Clinical Trial
  • Observational Study
  • Community Prevention Study
  • RESPONSES TO THE STATEMENT OF TASK
  • 1 Introduction
  • DESCRIPTION OF THE NIH WOMEN'S HEALTH INITIATIVE
  • HISTORY OF INSTITUTE OF MEDICINE INVOLVEMENT
  • COMMITTEE SELECTION AND PARTICIPATION
  • STATEMENT OF TASK
  • COMMITTEE ACTIVITIES
  • 2 Clinical Trial
  • INTRODUCTION
  • RATIONALE
  • General Issues
  • Integration of the CT with Other Components of the WHI
  • 3 Observational Study
  • RATIONALE
  • DESIGN AND METHODS
  • COST
  • RECOMMENDATIONS
  • 4 Community Prevention Study
  • INTRODUCTION
  • RATIONALE
  • DESIGN AND METHODS
  • COST
  • RECOMMENDATIONS
  • 5 Concluding Remarks
  • RESPONSE TO THE STATEMENT OF TASK
  • SOCIETAL CONTEXT
  • Efficacy and Effectiveness
  • Public Health Choice versus Individual Choice
  • Considerations beyond Science
  • References
  • Appendixes
  • A Clinical Trial Exclusion Criteria (June 28, 1993, WHI Protocol)
  • A.  EXCLUSION CRITERIA FOR ALL COMPONENTS
  • B.  ADDITIONAL EXCLUSION CRITERIA FOR ALL CLINICAL TRIAL COMPONENTS
  • C.  ADDITIONAL EXCLUSION CRITERIA FOR HORMONE REPLACEMENT COMPONENT
  • D.  ADDITIONAL EXCLUSION CRITERIA FOR DIETARY MODIFICATION COMPONENT
  • E.  ADDITIONAL EXCLUSION CRITERIA FOR CALCIUM/VITAMIN D COMPONENT.
  • B U.S. House of Representatives Appropriations Committee
  • C Statement of Task
  • D Documents Received by the Institute of Medicine from the National Institutes of Health
  • E Meeting Participants June, July, and August 1993
  • F Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial
  • G Women's Health Initiative Committees
  • H NIH-Sponsored Women's Health Studies
  • I NIH Cost and FTE Summary for Vanguard Clinical Centers
  • J NIH Power Calculations
  • K Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators
  • M Committee and Staff Biographies
  • IOM STAFF.